75Pharma officially launches in the UK in Boots

Transforming pharmaceuticals with purpose: 75Pharma Ibuprofen 400mg soft capsules in UK Boots stores.

London, UK 8^th of October 2025 – 75Pharma, a purpose-driven impact company in the pharmaceutical industry, is proud to announce its official entry into the UK and product launch in leading health and beauty retailer Boots. Launching on the 13th of October 2025, 75Pharma’s first UK product, premium 75Pharma Ibuprofen 400mg soft capsules, will be introduced over 1000 Boots stores and online.

This milestone represents an important step forward in 75Pharma’s mission to combine high-quality pharmaceutical products with responsible business practices and a commitment to creating positive long-term impact.nt to social good and environmental responsibility.

A New Standard for Purpose-Led Pharmaceuticals

The launch of 75Pharma in the UK represents an important milestone in the company’s mission to build a more responsible pharmaceutical business. By combining high-quality products with responsible business practices, 75Pharma aims to demonstrate that commercial success and positive impact can go hand in hand.

The partnership with Boots provides an opportunity to introduce the company’s approach to a wider audience and marks the first step in its broader growth ambitions across Europe.

Debut product in Boots stores starting 13th of October: 75Pharma Ibuprofen 400mg soft capsules

75Pharma’s first UK product is a premium soft gel formulation of ibuprofen 400mg, offering fast and effective pain relief while maintaining the highest standards of quality and safety. The product will be available to Boots customers from 13^th of October 2025, with broader retailer and pharmacy distribution planned for late autumn.

Created for the conscious consumer, the new product reflects 75Pharma’s commitment to:

• Environmentally responsible sourcing and manufacturing within Europe
• Competitive pricing without ethical compromise
• Effective high-quality products

Media & Partner Inquiries

75Pharma welcomes conversations with distributors, investors, healthcare providers, and media professionals.

• Sales & Distribution: sales@75pharmagroup.com
• Collaborations & Media: pr@75pharmagroup.com
• Investor Relations: investorrelations@75pharmagroup.com
• Website: www.75pharmagroup.com

About 75Pharma

75Pharma is an impact company built to create lasting change for people and the planet. With operations in London, Stockholm, and Helsinki, the company offers premium pharmaceutical products designed for conscious consumers who seek both therapeutic effectiveness and the opportunity to support ethical business practices. Its launch in the UK marks a significant step toward building a more responsible and sustainable pharmaceutical future, with further expansion as a first step into the Nordics planned as part of its broader European growth strategy.

75Pharma – A way to feel better